Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | ELV | COR | ICLR | AVTR |
| Company | Charles River Laboratories Intl | Elevance Health Inc | Cencora Inc | Icon Plc | Avantor Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NASDAQ | NYSE |
| Open | 236.00 | 533.65 | 223.95 | 312.26 | 24.28 |
| High | 238.91 | 539.38 | 225.50 | 315.73 | 24.79 |
| Low | 226.00 | 533.65 | 223.78 | 311.36 | 24.24 |
| Last | 230.09 | 538.58 | 224.09 | 315.04 | 24.77 |
| Change | -5.20 | +5.23 | +0.49 | +3.29 | +0.49 |
| % Change | -2.21% | +0.98% | +0.22% | +1.06% | +2.02% |
| Volume | 1,004,400 | 456,500 | 927,600 | 396,000 | 2,904,500 |
| 20-Day Average Volume | 525,720 | 1,080,030 | 1,549,470 | 606,330 | 5,132,095 |
| Previous Close | 235.29 | 533.35 | 223.60 | 311.75 | 24.28 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 232.85 | 526.20 | 233.52 | 303.18 | 24.61 |
| 20-Day Raw Stochastic | 28.60% | 92.69% | 9.86% | 88.87% | 53.00% |
| 20-Day Relative Strength | 42.29% | 61.84% | 35.57% | 53.55% | 50.28% |
| Weighted Alpha | +17.81 | +21.70 | +27.41 | +52.06 | +24.37 |
| Today's Opinion | 8% Buy | 100% Buy | 24% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 24% Buy | 56% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 72% Buy | 80% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.09% since 05/02/24 | +2.47% since 05/02/24 | -0.29% since 05/02/24 | +4.64% since 05/02/24 | +1.85% since 05/02/24 |
| Low | 226.00 on 05/09/24 | 518.90 on 05/03/24 | 222.20 on 05/03/24 | 303.23 on 05/03/24 | 24.17 on 05/08/24 |
| High | 238.91 on 05/09/24 | 539.76 on 05/08/24 | 228.25 on 05/08/24 | 317.24 on 05/07/24 | 24.99 on 05/07/24 |
| 1-Month | |||||
| %Chg | -10.52% since 04/09/24 | +4.70% since 04/09/24 | -6.07% since 04/09/24 | -1.28% since 04/09/24 | -4.22% since 04/09/24 |
| Low | 223.49 on 04/18/24 | 494.31 on 04/12/24 | 222.20 on 05/03/24 | 287.02 on 04/19/24 | 23.40 on 04/26/24 |
| High | 251.31 on 04/10/24 | 542.07 on 04/25/24 | 241.36 on 04/26/24 | 318.55 on 04/25/24 | 26.03 on 04/11/24 |
| 3-Month | |||||
| %Chg | +3.54% since 02/09/24 | +6.42% since 02/09/24 | -2.86% since 02/09/24 | +13.13% since 02/09/24 | +6.72% since 02/09/24 |
| Low | 216.50 on 02/13/24 | 492.06 on 03/01/24 | 222.20 on 05/03/24 | 272.14 on 02/13/24 | 21.68 on 02/13/24 |
| High | 275.00 on 03/08/24 | 542.07 on 04/25/24 | 246.75 on 04/03/24 | 344.77 on 03/06/24 | 26.16 on 03/25/24 |
| 6-Month | |||||
| %Chg | +35.77% since 11/09/23 | +18.88% since 11/09/23 | +13.86% since 11/09/23 | +25.72% since 11/09/23 | +34.69% since 11/09/23 |
| Low | 166.87 on 11/10/23 | 449.02 on 01/18/24 | 191.11 on 11/15/23 | 244.59 on 01/17/24 | 18.08 on 11/10/23 |
| High | 275.00 on 03/08/24 | 542.07 on 04/25/24 | 246.75 on 04/03/24 | 344.77 on 03/06/24 | 26.16 on 03/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,120,024 | 123,960,128 | 44,705,912 | 25,717,818 | 16,492,579 |
| Shares Outstanding, K | 51,511 | 232,418 | 199,482 | 82,495 | 679,266 |
| Annual Sales | 4,129,410,000 | 171,340,000,000 | 262,173,410,000 | 8,120,180,000 | 6,967,200,000 |
| Annual Net Income | 474,620,000 | 5,987,000,000 | 1,745,290,000 | 612,340,000 | 321,100,000 |
| Last Quarter Sales | 1,013,480,000 | 42,577,000,000 | 68,414,300,000 | 2,090,390,000 | 1,679,800,000 |
| Last Quarter Net Income | 187,080,000 | 2,246,000,000 | 420,780,000 | 187,440,000 | 60,400,000 |
| 60-Month Beta | 1.44 | 0.79 | 0.47 | 1.18 | 1.36 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.46 on 02/14/24 | 10.64 on 04/18/24 | 3.80 on 05/01/24 | 3.47 on 04/24/24 | 0.22 on 04/26/24 |
| Latest Earnings Date | 05/09/24 | 04/18/24 | 05/01/24 | 04/24/24 | 04/26/24 |
| Most Recent Dividend | N/A | 1.630 on 03/07/24 | 0.510 on 05/09/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 06/10/24 | 05/09/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 22.19 | 15.64 | 17.63 | 24.50 | 24.85 |